EPISODE · May 8, 2023 · 1H 3M
Ep135: John Maraganore on Developing a New Class of Medicines
from The Long Run with Luke Timmerman · host Timmerman Report
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
Embed this episode
NOW PLAYING
Ep135: John Maraganore on Developing a New Class of Medicines
0:00
1:03:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Long Run with Luke Timmerman?
This episode is 1 hour and 3 minutes long.
When was this The Long Run with Luke Timmerman episode published?
This episode was published on May 8, 2023.
Can I download this The Long Run with Luke Timmerman episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!